文献速递抗菌药物管理特殊人群用药

脓毒症病程中头孢曲松药动学变化及目标达成与结局的关联

Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.
PubMed 文献 · Pharmacotherapy · 2023-02-14

结果显示两阶段归一化清除率和中心容积相似但个体差异大,后期1×MIC目标达成率较低(82% vs 96%,p=0.013),且未达成目标与抗生素升级相关。

要点

  • 脓毒症早期与后期头孢曲松药动学参数总体相似,但个体间差异大。
  • 后期1×MIC目标达成率显著低于早期(82% vs 96%,p=0.013)。
  • 后期未达成目标与抗生素升级相关,提示抗菌药物管理干预点。

核心结论

  • 脓毒症早期与后期头孢曲松药动学参数相似,但个体差异大。
  • 后期1×MIC目标达成率较低,且未达成目标与抗生素升级相关。

研究设计与样本

  • 单中心儿科重症监护病房回顾性分析前瞻性研究数据。

主要发现

  • 归一化清除率早期6.18 ± 1.48 L/h/70 kg vs 后期6.10 ± 1.61 L/h/70 kg,p=0.60。
  • 中心容积早期26.6 [IQR 22.3, 31.3] L/70 kg vs 后期24.5 [IQR 22.0, 29.4] L/70 kg,p=0.18。
  • 归一化清除率和中心容积的个体百分比差异范围分别为-39%至276%和-51%至212%(参照后期)。
  • 后期1×MIC目标达成率82% vs 早期96%,p=0.013。
  • 后期未达成任一目标与抗生素升级相关。

关键数值与推荐

  • 目标达成定义为浓度在100%给药间隔内高于1×或4×最低抑菌浓度(MIC)。
  • 后期1×MIC目标达成率82% vs 早期96%,p=0.013。

临床怎么用

  • 脓毒症患儿使用头孢曲松时应关注后期目标达成率下降,尤其转为每日一次给药时。
  • 未达成目标与抗生素升级相关,可作为抗菌药物管理干预的切入点。

局限性

  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Early sepsis results in pharmacokinetic (PK) changes due to physiologic alterations. PK changes can lead to suboptimal drug target attainment, risking inadequate coverage from antibiotics like ceftriaxone. Little is known about how ceftriaxone PK and target attainment quantitatively change over time in patients with sepsis or the association between target attainment and outcomes in critically ill children and young adults. METHODS: A retrospective analysis of a prospective study was conducted in a single-center pediatric intensive care unit. Septic patients given at least one ceftriaxone dose (commonly as 50 mg/kg every 12 h) and who had blood obtained in both the first 48 h of therapy (early) and afterwards (late) were included. Normalized clearance and central volume were estimated and compared in both sepsis phases. We evaluated target attainment, defined as concentrations above 1× or 4× the minimum inhibitory concentration (MIC) for 100% of dosing intervals, and investigated the association between target attainment and clinical outcomes. RESULTS: Fifty-five septic patients (median age: 7.5 years) were included. Normalized clearance and central volume were similar in both phases (6.18 ± 1.48 L/h/70 kg early vs. 6.10 ± 1.61 L/h/70 kg late, p = 0.60; 26.6 [IQR 22.3, 31.3] L/70 kg early vs. 24.5 [IQR 22.0, 29.4] L/70 kg late, p = 0.18). Individual percent differences in normalized clearance and central volume between sepsis phases ranged from -39% to 276% and -51% to 212% (reference, late sepsis), respectively. Fewer patients attained the 1× MIC target in late sepsis (82% late vs. 96% early, p = 0.013), which was associated with transition to once daily dosing, typically done due to transfer from the pediatric intensive care unit (PICU) to a lower acuity unit. Failure to attain either target in late sepsis was associated with antibiotic broadening. CONCLUSION: Ceftriaxone PK parameters were similar between early and late sepsis, but there were large individual differences. Fewer patients attained MIC targets in late sepsis and all who did not attain the less stringent target received once daily dosing during this period. The failure to attain targets in late sepsis was associated with antibiotic broadening and could be an area for antibiotic stewardship intervention.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Tang Girdwood S, Tang P, Fenchel M, et al. Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone. Pharmacotherapy. 2023. PMID: 36727212. doi:10.1002/phar.2774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。